| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 96 |
| 1 | ACETAMINOPHEN | 31 |
| 2 | PANTOPRAZOLE | 28 |
| 3 | ERGOCALCIFEROL | 22 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE | 21 |
| 5 | ALEMTUZUMAB | 20 |
| 6 | METHYLPREDNISOLONE | 19 |
| 7 | PREDNISONE | 19 |
| 8 | ACETAMINOPHEN 500MG | 18 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-BVZR | 5 | 0.0071 |
| 1 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 2 | 0.0045 |
| 2 | DIFLUNISAL | 3 | 0.0037 |
| 3 | PONATINIB HYDROCHLORIDE | 11 | 0.0021 |
| 4 | CEFPODOXIME PROXETIL | 2 | 0.0020 |
| 5 | ONASEMNOGENE ABEPARVOVEC-XIOI | 4 | 0.0017 |
| 6 | ALEMTUZUMAB | 20 | 0.0010 |
| 7 | DIMENHYDRINATE | 11 | 0.0010 |
| 8 | HYDROCORTISONE BUTYRATE | 2 | 0.0010 |
| 9 | CLOZAPINE | 96 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 100 |
| 1 | Corticosteroid [EPC] | 51 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 45 |
| 3 | Kinase Inhibitor [EPC] | 27 |
| 4 | Benzodiazepine [EPC] | 26 |
| 5 | Loop Diuretic [EPC] | 26 |
| 6 | Osmotic Laxative [EPC] | 25 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 24 |
| 8 | Provitamin D2 Compound [EPC] | 22 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 20 | 0.0010 |
| 1 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 2 | Stimulant Laxative [EPC] | 6 | 0.0004 |
| 3 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 3 | 0.0004 |
| 5 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 2 | 0.0003 |
| 6 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 7 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Atypical Antipsychotic [EPC] | 100 | 0.0002 |
| 9 | Pediculicide [EPC] | 1 | 0.0002 |